Donald Gene Drake from 1 Augusta Ln, West Columbia, TX 77486, age 88

Resumes

Donald Drake

View page

Location:

West Columbia, TX

Industry:

Health, Wellness And Fitness

Work:

Cedar Ridge Hospital 2006 - 2012
Certified Dietary Maanager

Donald Drake

View page

Skills:

Leadership
Microsoft Office
Management
Microsoft Word
Powerpoint
Microsoft Excel
Training
Sales

Donald Drake

View page

Donald Drake

View page

Skills:

Microsoft Office
Microsoft Word

Donald Drake

View page

Donald Drake

View page

Donald Drake

View page

Business Records

Name / Title

Company / Classification

Phones & Addresses

Donald Drake
President

Marin County Athletic Legal Office
Membership Organization

375 Doherty Dr, Larkspur, CA 94939

Donald Drake
President

THE MARIN COUNTY ATHLETIC LEAGUE
Other Similar Organizations

375 Doherty Dr, Larkspur, CA 94939
(415) 924-4424

Donald Robert Drake
Incorporator

DRAKE, INCORPORATED

Donald L. Drake

DOUBLE D'S TOWING AND SALVAGE, INC

Publications

Wikipedia

Frank Drake

View page

Dr. Frank Donald Drake (born May 28, 1930, Chicago) is an American astronomer and astrophysicist. He is most famous for founding SETI and creating the Drake ...

Us Patents

In Vitro Germinal Centers

View page

US Patent:

20070218054, Sep 20, 2007

Filed:

Dec 21, 2006

Appl. No.:

11/642938

Inventors:

Selva Sukumar - Berkeley CA, US
Mohey Eldin El Shikh - Richmond VA, US
John Tew - Mechanicsville VA, US
Donald Drake - Orlando FL, US
Luis Mosquera - Oviedo FL, US
Eric Mishkin - Winter Springs FL, US
Anatoly Kachurin - Orlando FL, US
Russell Higbee - Orlando FL, US
Conan Li - Los Altos CA, US
William Warren - Orlando FL, US
Heather Fahlenkamp - Cleveland OK, US

International Classification:

A61K 39/395
G01N 33/567
C12P 21/04
C12N 5/08

US Classification:

424133100, 435372000, 435070210, 435007200

Abstract:

The present invention incorporates germinal centers (GCs) into three-dimensional (3D) engineered tissue constructs (ETCs). In an embodiment, we have incorporated the GC in the design of an artificial immune system (AIS) to examine immune responses to vaccines and other compounds. Development of an in vitro GC adds functionality to an AIS, in that it enables generation of an in vitro human humoral response by human B lymphocytes that is accurate and reproducible, without using human subjects. The invention also permits evaluation of, for example, vaccines, allergens, and immunogens, and activation of human B cells specific for a given antigen, which can then be used to generate human antibodies. In an embodiment of the present invention the function of the in vitro GC is enhanced by placing FDCs and other immune cells in a 3D ETC; FDCs appear more effective over a longer time (antibody production is sustained for up to about 14 days.